SG79901A1 - Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid - Google Patents

Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid

Info

Publication number
SG79901A1
SG79901A1 SG9603463A SG1996003463A SG79901A1 SG 79901 A1 SG79901 A1 SG 79901A1 SG 9603463 A SG9603463 A SG 9603463A SG 1996003463 A SG1996003463 A SG 1996003463A SG 79901 A1 SG79901 A1 SG 79901A1
Authority
SG
Singapore
Prior art keywords
alpha
treating
salt
composition
carboxylic acid
Prior art date
Application number
SG9603463A
Other languages
English (en)
Inventor
Parab Prakash
Lavker Robert
Leyden James
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SG79901A1 publication Critical patent/SG79901A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
SG9603463A 1991-03-19 1992-03-18 Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid SG79901A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67157791A 1991-03-19 1991-03-19

Publications (1)

Publication Number Publication Date
SG79901A1 true SG79901A1 (en) 2001-04-17

Family

ID=24695083

Family Applications (2)

Application Number Title Priority Date Filing Date
SG9603463A SG79901A1 (en) 1991-03-19 1992-03-18 Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid
SG9904360-6A SG141206A1 (en) 1991-03-19 1992-03-18 Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG9904360-6A SG141206A1 (en) 1991-03-19 1992-03-18 Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid

Country Status (16)

Country Link
US (2) US5254343A (ko)
EP (1) EP0504862B1 (ko)
JP (1) JP3504279B2 (ko)
KR (1) KR100193993B1 (ko)
AT (1) ATE141050T1 (ko)
AU (1) AU655005B2 (ko)
CA (1) CA2063127C (ko)
DE (1) DE69212610T2 (ko)
DK (1) DK0504862T3 (ko)
ES (1) ES2090390T3 (ko)
GR (1) GR3020779T3 (ko)
HK (1) HK1004532A1 (ko)
IE (1) IE920859A1 (ko)
SG (2) SG79901A1 (ko)
TW (1) TW208658B (ko)
ZA (1) ZA921821B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy
US5420106A (en) * 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
CA2143515A1 (en) * 1994-03-22 1995-09-23 Prakash Parab Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5683705A (en) * 1996-03-29 1997-11-04 Estee Lauder, Inc. Sulfur-based amides and bis-amides useful against skin disorders
US5993792A (en) * 1997-11-13 1999-11-30 Tiro Industries Incorporated System for customized hair products containing surfactants
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
CA2439687A1 (en) 2001-03-01 2002-09-12 Hollis-Eden Pharmaceuticals, Inc. Use of certain steroids for treatment of blood cell deficiencies
WO2002096374A2 (en) 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
CA2496867A1 (en) 2002-08-28 2004-03-11 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment methods
CA2582231A1 (en) 2004-09-29 2006-10-19 Hollis-Eden Pharmaceuticals, Inc. Steroid analogs and uses
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
DE102014209988A1 (de) * 2014-05-26 2015-11-26 Deb Ip Limited Aluminiumlactat als Hautschutzkomponente

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105783A (en) * 1975-07-23 1978-08-08 Yu Ruey J Therapeutic treatment of dry skin
US4246261A (en) * 1979-08-09 1981-01-20 Scott Eugene J Van Additives enhancing topical corticosteroid action
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4380549A (en) * 1975-07-23 1983-04-19 Scott Eugene J Van Topical treatment of dry skin
US4485091A (en) * 1980-07-15 1984-11-27 Quinoderm Limited Dermatological compositions
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
US4937068A (en) * 1988-10-31 1990-06-26 Jim Baral Sun tanning medication and treatment
EP0413528A1 (en) * 1989-08-15 1991-02-20 Ruey J. Dr. Yu Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
EP0273202B1 (en) * 1986-12-23 1995-06-21 Eugene J. Dr. Van Scott Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH13782A (en) * 1976-09-07 1980-09-26 E Scott Therapeutic treatment of dry skin
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105783A (en) * 1975-07-23 1978-08-08 Yu Ruey J Therapeutic treatment of dry skin
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4380549A (en) * 1975-07-23 1983-04-19 Scott Eugene J Van Topical treatment of dry skin
US4246261A (en) * 1979-08-09 1981-01-20 Scott Eugene J Van Additives enhancing topical corticosteroid action
US4485091A (en) * 1980-07-15 1984-11-27 Quinoderm Limited Dermatological compositions
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
EP0273202B1 (en) * 1986-12-23 1995-06-21 Eugene J. Dr. Van Scott Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots.
US4937068A (en) * 1988-10-31 1990-06-26 Jim Baral Sun tanning medication and treatment
EP0413528A1 (en) * 1989-08-15 1991-02-20 Ruey J. Dr. Yu Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use

Also Published As

Publication number Publication date
CA2063127A1 (en) 1992-09-20
US5254343A (en) 1993-10-19
JP3504279B2 (ja) 2004-03-08
SG141206A1 (en) 2008-04-28
JPH05117144A (ja) 1993-05-14
ES2090390T3 (es) 1996-10-16
AU1295592A (en) 1992-09-24
DE69212610D1 (de) 1996-09-12
HK1004532A1 (en) 1998-11-27
KR920017648A (ko) 1992-10-21
ATE141050T1 (de) 1996-08-15
IE920859A1 (en) 1992-09-23
ZA921821B (en) 1993-01-27
GR3020779T3 (en) 1996-11-30
CA2063127C (en) 2002-01-29
US5807600A (en) 1998-09-15
KR100193993B1 (ko) 1999-06-15
EP0504862A1 (en) 1992-09-23
DE69212610T2 (de) 1997-03-27
TW208658B (ko) 1993-07-01
DK0504862T3 (da) 1996-09-02
EP0504862B1 (en) 1996-08-07
AU655005B2 (en) 1994-12-01

Similar Documents

Publication Publication Date Title
SG79901A1 (en) Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of c3-7 alpha-hydroxy carboxylic acid
EG19012A (en) Low volatility salts
DE69507199D1 (de) Heterocyclylcarbonylsubstituierte Benzofuranyl- und -thiophenylalkancarbonsäurederivate
ZA899669B (en) Sulfonic acid substituted aromatic steroids as inhibitors of steroid 5-alpha-reductase
ES553043A1 (es) Un procedimiento para la preparacion de composiciones lubricantes constituidas esencialmente por un aceite de viscosidad lubricante.
HU9501799D0 (en) Substituted triols
UA43317C2 (uk) Ароматичні похідні карбонової кислоти та фармацевтична композиція
HUT62194A (en) Process for producing pharmaceutical composition with tenidap content, reducing the concentration of total serum cholesterol, ldl cholesterol and triglycerides
EP0470431A3 (en) Use of phosphomycin and the pharmaceutically acceptable salts thereof as a topical cicatrizer
HU9601167D0 (en) 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
GR82222B (ko)
AU6432986A (en) 1-methyl-15alpha -alkylandrosta-1, 4-diene-3, 17-diones
JPS51121163A (en) Switching regulator
FI862634A (fi) Spiro-heteroazaloner foer vaord av komplikationer vid diabetes.
JPS5312058A (en) Dc power controlling apparatus
DE60018647T8 (de) Verwendung von 4,6-Dimethoxyindol-2-carbonsäure oder ihren Derivaten zur Behandlung von Seborrhoe
JPS52101389A (en) Biric acid conc. controller in primary coolant in atomic power plant
AU564328B2 (en) 2 - (formylamino) -n- (1h-tetrazol-5-yl) - benzimide
AU4356489A (en) Branched-chain alkyl esters of 2-(4-(2-piperidino-ethoxy)- benzoyl)-benzoic acid, processes for their preparation and their use as spasmolytic agents
JPS5558840A (en) Tape running control mechanism
JPS5442109A (en) Motor control circuit of magnetic recorder-reproducer
JPS6442047A (en) Microcassette recorder
JPS52100123A (en) Controller for tap position of tap switching transformer when load is provided
JPS52109489A (en) Absorptive solution for desulphurization and denitration and its devic e
JPS5383057A (en) Transistor switch control